[1] MEZZANO G, JUANOLA A, CARDENAS A, et al.Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis[J]. Gut, 2022, 71(1): 148-155. [2] LI J, LIANG X, YOU S, et al.Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure[J]. J Hepatol, 2021, 75(5): 1104-1115. [3] GARCÍA-ESCOBAR A, VERA-VERA S, TÉBAR-MÁRQUEZ D, et al. Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: New insights for a potential predictor of anti-cytokine therapy responsiveness[J]. Microvasc Res, 2023, 150: 104598. [4] BUONACERA A, STANCANELLI B, COLACI M, et al.Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases[J]. Int J Mol Sci, 2022, 23(7): 3636. [5] 尤红, 王福生, 李太生, 等. 慢性乙型肝炎防治指南(2022年版)[J]. 实用肝脏病杂志, 2023, 26(3): 457-478. [6] 中华医学会肝病学分会重型肝病与人工肝学组, 中华医学会感染病学分会肝衰竭与人工肝学组. 肝衰竭诊治指南(2024年版)[J]. 临床肝胆病杂志, 2024, 40(12): 2371-2387. [7] KAMATH PS, WIESNER RH, MALINCHOC M, et al.A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2): 464-470. [8] BIGGINS SW, KIM WR, TERRAULT NA, et al.Evidence-based incorporation of serum sodium concentration into MELD[J]. Gastroenterology, 2006, 130(6): 1652-1660. [9] KIM WR, MANNALITHARA A, HEIMBACH JK, et al. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era[J]. Gastroenterology, 2021, 161(6): 1887-1895.e4. [10] HEUMAN DM, MIHAS AA, HABIB A, et al.MELD-Ⅺ: a rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapy[J]. Liver Transpl, 2007, 13(1): 30-37. [11] LUCA A, ANGERMAYR B, BERTOLINI G, et al.An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis[J]. Liver Transpl, 2007, 13(8): 1174-1180. [12] HUO TI, WANG YW, YANG YY, et al.Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis[J]. Liver Transpl, 2007, 27(4): 498-506. [13] 张旭, 马丽娜, 吴丽娜, 等. 系统性炎症反应指数对乙型病毒性肝炎相关慢加急性肝衰竭患者短期预后的预测价值[J]. 中国实用内科杂志, 2023, 43(11): 907-914. [14] 张冬青, 郑瑞丹, 林明华, 等. HBV相关慢加急性肝衰竭患者90天预后影响因素分析[J]. 临床肝胆病杂志, 2021, 37(10): 2316-2319. [15] JIANG M, LIU F, ⅪONG WJ, et al.Comparison of four models for end-stage liver disease in evaluating the prognosis of cirrhosis[J]. WJG, 2008, 14(42): 6546-6550. [16] CHEN PC, CHEN BH, HUANG CH, et al.Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis[J]. Eur J Gastroenterol Hepatol, 2019, 31(10): 1256-1263. [17] 郭北辰, 李雨韩, 陈蕊, 等. MELD 3.0、MELD和MELD-Na评分对慢加急性肝衰竭患者短期预后的评估价值[J]. 临床肝胆病杂志, 2023, 39(11): 2635-2642. [18] CUPP MA, CARIOLOU M, TZOULAKI I, et al.Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies[J]. BMC Med, 2020, 18(1): 360-375. [19] CHEN T, YANG Z, CHOUDHURY AK, et al.Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region[J]. Hepatology Int, 2019, 13(6): 695-705. [20] LIU J, LI H, ⅪA J, et al.Baseline Neutrophil-to-Lymphocyte Ratio Is Independently Associated With 90-Day Transplant-Free Mortality in Patients With Cirrhosis[J]. Front Med, 2021, 8: 726950. [21] DENG Y, FAN X, RAN Y, et al.Prognostic impact of neutrophil-to-lymphocyte ratio in cirrhosis: A propensity score matching analysis with a prespecified cut-point[J]. Liver Int, 2019, 39(11): 2153-2163. [22] WANG Y, PENG C, CHENG Z, et al.The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis[J]. Int J Surg, 2018, 55: 73-80. [23] CLÀRIA J, STAUBER RE, COENRAAD MJ, et al. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure[J]. Hepatology, 2016, 64(4): 1249. [24] WANG Y, DONG F, SUN S, et al.Increased INR Values Predict Accelerating Deterioration and High Short-Term Mortality Among Patients Hospitalized With Cirrhosis or Advanced Fibrosis[J]. Front Med(Lausanne), 2021, 8: 762291. [25] MA Y, XU Y, DU L, et al.Outcome of patients with different stages of acute-on-chronic liver failure treated with artificial liver support system[J]. Front Med(Lausanne), 2024, 11: 1381386. [26] TU H, LIU R, ZHANG A, et al.Risk factors for the mortality of hepatitis B virus-associated acute-on-chronic liver failure: a systematic review and meta-analysis[J]. BMC gastroenterology, 2023, 23(1): 342. |